Provention Bio, Inc. Gains 28.85%
Mon, Jan 31, 2022 at 05:30 PM
Provention Bio, Inc. (PRVB:NASDAQ) soared at $5.36, a gain of 28.8%. The stock appeared on our News Catalysts scanner on Fri, Jan 28, 2022 at 02:43 PM in the 'MISCELLANEOUS' category. From Tue, Jan 18, 2022, the stock recorded 25.00% Up Days and 44.44% Green Days
The stock spiked on Mon, Nov 22, 2021 at $7.72 with a volume of 6M+.
About Provention Bio, Inc. (PRVB:NASDAQ)
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The company's pipeline includes PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-101.
Top 10 Gainers:
- Calithera Biosciences, Inc. (CALA:NASDAQ), 55.65%
- Inspira Technologies Oxy B.H.N. Ltd. (IINN:NASDAQ), 36.52%
- Vaccinex, Inc. (VCNX:NASDAQ), 33.63%
- Bassett Furniture Industries, Incorporated (BSET:NASDAQ), 33.14%
- Knightscope Inc. (KSCP:NASDAQ), 31.37%
- FGI Industries Ltd. (FGI:NASDAQ), 28.91%
- Provention Bio, Inc. (PRVB:NASDAQ), 28.85%
- Astria Therapeutics Inc. (ATXS:NASDAQ), 27.48%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 26.8%
- Romeo Power Inc. Class A (RMO:NYSE), 25.53%